ENDRA Life Sciences Inc. SEC filings NDRA

ENDRA Life Sciences Inc. has 545 filings in SEC EDGAR's recent list, going back to Aug 9, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (material agreement). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders Oct 28, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 7, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Jun 25, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
ARS Annual report to shareholders May 24, 2023 Dec 31, 2022
10-K Annual report Mar 16, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
10-K Annual report Mar 11, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 13, 2018 Dec 31, 2017
10-K Annual report Mar 20, 2018 Dec 31, 2017

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NDRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ann Arbor, MI
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1681682
Former names
Endra Inc. (until Sep 21, 2016)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.